Liver
Publisher
Springer-Verlag
Reference173 articles.
1. Yamagami T, Nakamura T, Sato O, Takeuchi Y, Nishimura T. Value of intraarterial prostaglandin E(1) injection during CT hepatic arteriography. AJR 2001;177:115–119.
2. Sahani DV, Kalva SP, Tanabe KK, et al. Intraoperative US in patients undergoing surgery for liver neoplasms: comparison with MR imaging. Radiology 2004;232:810–814.
3. Bryant TH, Blomley MJ, Albrecht T, et al. Improved characterization of liver lesions with liver-phase uptake of liver-specific microbubbles: prospective multicenter study. Radiology 2004;232:799–809.
4. Blomley MJ, Sidhu PS, Cosgrove DO, et al. Do different types of liver lesions differ in their uptake of the microbubble contrast agent SH U 508A in the late liver phase? Early experience. Radiology 2001;220:661–667.
5. Robbin ML, Eisenfeld AJ. Perflenapent emulsion: a US contrast agent for diagnostic radiology-multicenter, double-blind comparison with a placebo. EchoGen Contrast Ultrasound Study Group. Radiology 1998;207:717–722.